Cas:3404-78-2 2,5-dimethyl-2-hexene manufacturer & supplier

Chemical Name:2,5-dimethyl-2-hexene

CAS.NO:3404-78-2

Synonyms:2,5-Dimethyl-2-hexene;2-hexene,2,5-dimethyl;2,5-Dimethyl-hex-2-en;2,5-dimethyl-hex-2-ene

Molecular Formula:C₈H₁₆

Molecular Weight:112.21300

HS Code:2901299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:113ºC

Density:0.72 g/cm3

Index of Refraction:1.418

PSA:

Exact Mass:112.12500

LogP:2.99870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1216

Packing Group:

Contact us for information like 2,5-Dimethyl-2-hexene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,5-dimethyl-hex-2-ene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5-Dimethyl-2-hexene Use and application,2,5-Dimethyl-hex-2-en technical grade,usp/ep/jp grade.

Related News: The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January. 2,5-dimethyl-2-hexene manufacturer Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2,5-dimethyl-2-hexene supplier The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 2,5-dimethyl-2-hexene vendor Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 2,5-dimethyl-2-hexene factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.